These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24646118)

  • 1. Overcoming scientific and structural bottlenecks in antibacterial discovery and development.
    Zorzet A
    Ups J Med Sci; 2014 May; 119(2):170-5. PubMed ID: 24646118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and development of new antibacterial drugs: learning from experience?
    Jackson N; Czaplewski L; Piddock LJV
    J Antimicrob Chemother; 2018 Jun; 73(6):1452-1459. PubMed ID: 29438542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery research: the scientific challenge of finding new antibiotics.
    Livermore DM;
    J Antimicrob Chemother; 2011 Sep; 66(9):1941-4. PubMed ID: 21700626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antibiotic resistance crisis and the development of new antibiotics.
    Brüssow H
    Microb Biotechnol; 2024 Jul; 17(7):e14510. PubMed ID: 38970161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems-Level Chemical Biology to Accelerate Antibiotic Drug Discovery.
    Farha MA; French S; Brown ED
    Acc Chem Res; 2021 Apr; 54(8):1909-1920. PubMed ID: 33787225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic tools to profile antibiotic mode of action.
    Cardona ST; Selin C; Gislason AS
    Crit Rev Microbiol; 2015; 41(4):465-72. PubMed ID: 24617440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges of antibacterial discovery revisited.
    Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus.
    Morel CM; Lindahl O; Harbarth S; de Kraker MEA; Edwards S; Hollis A
    J Antibiot (Tokyo); 2020 Jul; 73(7):421-428. PubMed ID: 32203126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H; Sass P
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Technology in the Discovery and Development of Novel Antibacterials.
    Chung PY
    Curr Drug Targets; 2018; 19(7):832-840. PubMed ID: 28891454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platforms for antibiotic discovery.
    Lewis K
    Nat Rev Drug Discov; 2013 May; 12(5):371-87. PubMed ID: 23629505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategies for antibacterial drug design: targeting non-multiplying latent bacteria.
    Coates AR; Hu Y
    Drugs R D; 2006; 7(3):133-51. PubMed ID: 16752940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of antibiotics.
    Spellberg B
    Crit Care; 2014 Jun; 18(3):228. PubMed ID: 25043962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renaissance in Antibiotic Discovery: Some Novel Approaches for Finding Drugs to Treat Bad Bugs.
    Gadakh B; Van Aerschot A
    Curr Med Chem; 2015; 22(18):2140-58. PubMed ID: 25787965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food for thought: Opportunities to target carbon metabolism in antibacterial drug discovery.
    Tong M; Brown ED
    Ann N Y Acad Sci; 2023 Jun; 1524(1):51-64. PubMed ID: 37005709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The millennium bugs--the need for and development of new antibacterials.
    Bax R; Mullan N; Verhoef J
    Int J Antimicrob Agents; 2000 Sep; 16(1):51-9. PubMed ID: 11185414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs.
    Kim W; Hendricks GL; Lee K; Mylonakis E
    Expert Opin Drug Discov; 2017 Jun; 12(6):625-633. PubMed ID: 28402221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Something old, something new: revisiting natural products in antibiotic drug discovery.
    Wright GD
    Can J Microbiol; 2014 Mar; 60(3):147-54. PubMed ID: 24588388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time for a change: addressing R&D and commercialization challenges for antibacterials.
    Payne DJ; Miller LF; Findlay D; Anderson J; Marks L
    Philos Trans R Soc Lond B Biol Sci; 2015 Jun; 370(1670):20140086. PubMed ID: 25918443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.